News | August 17, 2009

Elekta Wins Multiple Orders of Elekta Systems from ICESP in Brasil

August 17, 2009 - Elekta has received a multiple order of six radiation therapy systems from the Cancer Institute of the State of São Paulo. The order encompasses two Elekta Synergy Platform, three Elekta Synergy and one Elekta Axesse. Elekta will make the institute its training and product development center in Latin America.

The Cancer Institute of the State of São Paulo, ICESP, is a social organization of Health, created by the State Government in partnership with the Foundation School of Medicine to be the largest hospital specializing in the treatment of cancer in Latin America.

By winning this public tender, Elekta will make the institute its training and product development center in Latin America with the entire product portfolio available including hardware, software, planning system, management system and linear accelerators. The institute will be equipped with two Elekta Synergy Platform, three Elekta Synergy, one Elekta Axesse, 30 MOSAIQ stations and 19 CMS treatment planning systems.

About 6,000 patients diagnosed with cancer are treated at the institute every month, and attended by some of Brazil's most qualified professionals in this specialty. A key feature of the institute is the innovation in assistance, which allows the patient to have all phases of his care, diagnosis and rehabilitation, integrated in the same place.

Besides medical care, the professionals of ICESP develop teaching and research activities in accordance with the medical model of education introduced by the University of São Paulo Medicine - USP. The goal is to transform the institute into a research center of international reference in the area of cancer, including the study of new drugs and innovative treatments for the disease.

Elekta started its own subsidiary in São Paulo in the beginning of 2008, an investment, which has been a success. The Latin American market has successfully proved to be a growth market for Elekta.

Elekta Synergy Platform is a unique linear accelerator that is X-ray volume imaging (XVI) - ready. Based on the IMRT technology developed by Elekta, modifications have been undertaken in order to maintain isocenter accuracy and stability while incorporating the facility to add the additional weight of imaging, detector and robotic technology into the drum design of the treatment machine at a later stage.

Elekta Synergy, the first advanced multi-functional linear accelerator with intensity modulated radiation therapy (IMRT) and image guided radiation therapy (IGRT), enables clinicians to both image and treat patients in the same frame of reference, at the time of treatment. The result is unmatched clinical confidence, enabling more aggressive treatment of tumors while minimizing damage to surrounding healthy tissue.

Elekta Axesse is a fully integrated stereotactic system that combines true three-dimensional (3D) image guidance at the time of treatment with highly conformal beam shaping and robotic 6D sub-millimeter patient positioning to deliver fast, efficient and accurate treatment.

MOSAIQ is an image-enabled oncology electronic medical record (EMR) with fully integrated business features such as scheduling, billing and management reporting and analysis.

For more information: www.elekta.com

Related Content

RayStation Selected for New Carbon Ion Therapy Center in Japan
News | Treatment Planning | January 18, 2018
January 18, 2018 – RayStation has been chosen as the treatment planning system for a new carbon-ion therapy facility
Raysearch Receives First Order for the Raycare Oncology Information System
News | Oncology Information Management Systems (OIMS) | January 18, 2018
January 18, 2018 – Anderson Regional Cancer Center (ARCC) in Meridian, Mississippi, has placed the first order for...
Mevion Receives 510(k) Clearance for Hyperscan Pencil Beam Scanning Proton Therapy
Technology | Proton Therapy | January 04, 2018
Mevion Medical Systems has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the Mevion S250i...
Study Compares Radiosurgery and Whole-Brain Radiation in Lung Cancer Patients With Multiple Brain Metastases
News | Radiation Therapy | January 03, 2018
Although targeted therapies have produced dramatic advances in the ability to control some types of advanced lung...
MEDraysintell Downgrades Proton Therapy Market Projection for 2030
News | Proton Therapy | January 02, 2018
MEDraysintell recently downgraded its projection for proton therapy rooms expected to be operational in 2030 from 1,200...
California US Oncology Network Centers Adopt Xoft Electronic Brachytherapy System for Early-Stage Non-Melanoma Skin Cancer
News | Brachytherapy Systems | January 02, 2018
iCAD Inc. announced that its Xoft Axxent Electronic Brachytherapy (eBx) System is now available at two California-based...
Blue Phantom System Used for Acceptance of First European Varian Halcyon Machine
News | Radiation Therapy | January 02, 2018
IBA (Ion Beam Applications S.A.) announced in November the acceptance and beam model validation of the first Varian...
Study Finds Link Between Breast Cancer Treatments and Cellular Aging Markers
News | Women's Health | January 02, 2018
January 2, 2018 — A new study found women who had received chemotherapy and/or...
ACR Appropriateness Criteria Adds and Revises Topics for December 2017
News | Clinical Decision Support | December 29, 2017
December 29, 2017 — Radiologists can enhance the quality and effectiveness of care with the newest release of the ACR
FDA Clears GammaPod Stereotactic Radiotherapy System for Breast Cancer Treatment
Technology | Stereotactic Body Radiation Therapy (SBRT) | December 22, 2017
The U.S. Food and Drug Administration (FDA) has cleared the new GammaPod noninvasive stereotactic radiotherapy system...
Overlay Init